Related Experiment Video
Updated: Dec 24, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT)
Jingang Shen1, Xianbao Lv1, Lei Zhang2
1Department of Urology, Chengwu County People's Hospital, Shandong 274200, People's Republic of China.
Purpose:
GRHL2 played important roles in different cancers. In this study, we aimed to investigate the roles of GRHL2 in bladder cancer.
Methods:
The immunohistochemistry assay was performed to detect the expression of GRHL2 in bladder cancer tissues and adjacent noncancerous tissues and the expression levels of GRHL2 and zinc finger E-box binding homeobox (ZEB1) mRNA in tissues were determined by qRT-PCR. In addition, qRT-PCR and Western blotting were applied to detect the expression levels of GRHL2 and ZEB1 in bladder cancer cell lines (RT4, BIU-87, 5637, T24) and immortalized human bladder epithelial cell line (SV-HUC-1). The cell models with up-regulated and down-regulated expression of GRHL2 were constructed using bladder cancer cell lines T24 and 5637 to investigate the underlying roles of GRHL2 on the proliferation, migration, invasion and EMT process of bladder cancer cells. After that, cell proliferation was evaluated by CCK8 assay, cell cycle assay and colony formation assay. Transwell assay and wound healing assay were performed to determine the invasion and migration ability of the bladder cancer cells. The expressions of epithelial-mesenchymal transition (EMT) related proteins (E-cadherin, Vimentin, Slug and Snail) were assessed by Western blot analysis. Moreover, ZEB1 and GRHL2 were co-transfected into T24 and 5637 cells and their effects on EMT process and invasive capacity of cells were examined.
Results:
The expression of GRHL2 was down-regulated in bladder cancer tissues and human bladder cancer cell lines compared with the normal bladder tissues and immortalized human bladder epithelial cell line. Besides, down-regulation of GRHL2 improved the proliferation ability of bladder cancer cells and promoted the EMT process through up-regulation of ZEB1. The overexpression of ZEB1 partially reversed the inhibitory effect of GRHL2 on EMT.
Conclusion:
GRHL2 acts as an anti-oncogene to regulate bladder cancer cell proliferation and inhibit EMT by targeting ZEB1. This study may provide a theoretical basis for further research.
Insights
The study found that GRHL2 acts as an anti-oncogene in bladder cancer, inhibiting cell proliferation and epithelial-mesenchymal transition (EMT) by targeting ZEB1. This research offers a basis for future bladder cancer studies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- GRHL2 (Grainy-like protein 2) is implicated in various cancers.
- Understanding GRHL2's role in bladder cancer is crucial for therapeutic development.
Purpose of the Study:
- To investigate the function of GRHL2 in bladder cancer.
- To explore the relationship between GRHL2, cell proliferation, and EMT.
Main Methods:
- Immunohistochemistry and qRT-PCR to assess GRHL2 and ZEB1 expression in tissues and cell lines.
- Cell models with altered GRHL2 expression to evaluate proliferation, migration, invasion, and EMT.
- Western blotting to analyze EMT markers.
Main Results:
- GRHL2 expression is reduced in bladder cancer tissues and cell lines.
- Downregulation of GRHL2 enhances bladder cancer cell proliferation and promotes EMT via ZEB1 upregulation.
- ZEB1 overexpression partially counteracted GRHL2's inhibitory effects on EMT.
Conclusions:
- GRHL2 functions as an anti-oncogene in bladder cancer, suppressing proliferation and EMT.
- GRHL2 targets ZEB1 to exert its anti-cancer effects.
- Findings provide a foundation for further bladder cancer research.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
Mitogens and the Cell Cycle
The Ras Gene
Ras is a...

